Private practice with Dr Seth BilazarianView all posts »
Niacin in AIM-HIGH: What implications for the practitioner?Nov 15, 2011 11:20 EST
The conclusion from the AIM-HIGH trial is relatively straight-forward: niacin for secondary prevention didn't work for any of the patient subgroups in the study. What are the implications of these results for your practice?
To read a summary of the trial and my interpretation, download this slideset.
- AIM-HIGH: Results raise controversy over early stopping
- What future for niacin after AIM-HIGH?
- NIH pulls plug on AIM-HIGH trial with niacin
- Learning from AIM-HIGH